MovDisordV3, PubMed, Checkpoint, bibRecord, 001865

Gender differences in Parkinson's disease: clinical characteristics and cognition.

Identifieur interne : 001865 ( PubMed/Checkpoint ); précédent : 001864; suivant : 001866

Gender differences in Parkinson's disease: clinical characteristics and cognition.

Auteurs : Ivy N. Miller [États-Unis] ; Alice Cronin-Golomb

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.

RBID : pubmed:20925068

English descriptors

KwdEn :
- Brain (physiopathology), Cognition (physiology), Estrogens (physiology), Female, Humans, Male, Parkinson Disease (diagnosis), Parkinson Disease (physiopathology), Sex Characteristics.
MESH :
- chemical , physiology : Estrogens.
- diagnosis : Parkinson Disease.
- physiology : Cognition.
- physiopathology : Brain, Parkinson Disease.
- Female, Humans, Male, Sex Characteristics.

Abstract

More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male-female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease.

DOI: 10.1002/mds.23388
PubMed: 20925068

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001534
to stream PubMed, to step Curation: 001534

Links to Exploration step

pubmed:20925068

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gender differences in Parkinson's disease: clinical characteristics and cognition.</title>
<author><name sortKey="Miller, Ivy N" sort="Miller, Ivy N" uniqKey="Miller I" first="Ivy N" last="Miller">Ivy N. Miller</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, Boston University, Boston, Massachusetts</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cronin Golomb, Alice" sort="Cronin Golomb, Alice" uniqKey="Cronin Golomb A" first="Alice" last="Cronin-Golomb">Alice Cronin-Golomb</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23388</idno>
<idno type="RBID">pubmed:20925068</idno>
<idno type="pmid">20925068</idno>
<idno type="wicri:Area/PubMed/Corpus">001534</idno>
<idno type="wicri:Area/PubMed/Curation">001534</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001865</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Gender differences in Parkinson's disease: clinical characteristics and cognition.</title>
<author><name sortKey="Miller, Ivy N" sort="Miller, Ivy N" uniqKey="Miller I" first="Ivy N" last="Miller">Ivy N. Miller</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, Boston University, Boston, Massachusetts</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cronin Golomb, Alice" sort="Cronin Golomb, Alice" uniqKey="Cronin Golomb A" first="Alice" last="Cronin-Golomb">Alice Cronin-Golomb</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (physiopathology)</term>
<term>Cognition (physiology)</term>
<term>Estrogens (physiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Estrogens</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cognition</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Sex Characteristics</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male-female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20925068</PMID>
<DateCreated><Year>2010</Year>
<Month>12</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>04</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>09</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>16</Issue>
<PubDate><Year>2010</Year>
<Month>Dec</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Gender differences in Parkinson's disease: clinical characteristics and cognition.</ArticleTitle>
<Pagination><MedlinePgn>2695-703</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23388</ELocationID>
<Abstract><AbstractText>More men than women are diagnosed with Parkinson's disease (PD), and a number of gender differences have been documented in this disorder. Examples of clinical characteristics that appear in men more often than women include rigidity and rapid eye movement behavior disorder, whereas more women than men exhibit dyskinesias and depression. Differences between men and women in cognition have not been extensively examined, though there are reports of deficits in men in aspects of cognition that contribute to activities of daily living, in verbal fluency, and in the recognition of facial emotion, and deficits in women in visuospatial cognition. Side of disease onset may interact with gender to affect cognitive abilities. One possible source of male-female differences in the clinical and cognitive characteristics of PD is the effect of estrogen on dopaminergic neurons and pathways in the brain. This effect is not yet understood, as insight into how the fluctuation of estrogen over the lifetime affects the brain is currently limited. Further attention to this area of research will be important for accurate assessment and better management of PD. Attention should also be directed to multiple covariates that may affect clinical characteristics and cognition. Knowledge about differences in the presentation of PD symptoms in men and women and about the pathophysiology underlying those differences may enhance the accuracy and effectiveness of clinical assessment and treatment of the disease.</AbstractText>
<CopyrightInformation>© 2010 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName>
<ForeName>Ivy N</ForeName>
<Initials>IN</Initials>
<AffiliationInfo><Affiliation>Department of Psychology, Boston University, Boston, Massachusetts, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cronin-Golomb</LastName>
<ForeName>Alice</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>1 R01 NS050446-01</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS050446</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS050446-01A2</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NS067128</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004967">Estrogens</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2000 May;15(3):490-6</RefSource>
<PMID Version="1">10830414</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychol Rev. 2010 Jun;20(2):191-208</RefSource>
<PMID Version="1">20383586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Nucl Med. 2000 Jul;27(7):867-9</RefSource>
<PMID Version="1">10952500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Gend Specif Med. 2000 Sep-Oct;3(6):36-42</RefSource>
<PMID Version="1">11253381</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2001 Sep;158(9):1492-9</RefSource>
<PMID Version="1">11532737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2002;40(4):411-22</RefSource>
<PMID Version="1">11684174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2002 Mar-Apr;25(2):79-82</RefSource>
<PMID Version="1">11981233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Exp Neuropsychol. 2003 Feb;25(1):94-109</RefSource>
<PMID Version="1">12607175</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2003 Jun 1;157(11):1015-22</RefSource>
<PMID Version="1">12777365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2003 Jul;108(1):28-37</RefSource>
<PMID Version="1">12807390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2003 Jul 16;23(15):6351-6</RefSource>
<PMID Version="1">12867520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cogn Neurosci. 2003 Nov 15;15(8):1232-43</RefSource>
<PMID Version="1">14709239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2004;42(5):624-32</RefSource>
<PMID Version="1">14725800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2004 Jun;22(2):553-61</RefSource>
<PMID Version="1">15193583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 1975 Nov;12(3):189-98</RefSource>
<PMID Version="1">1202204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 1987 Jan;47(1):94-100</RefSource>
<PMID Version="1">3539646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 1997 Jan;11(1):44-52</RefSource>
<PMID Version="1">9055268</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vision Res. 2005 May;45(10):1285-96</RefSource>
<PMID Version="1">15733961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Neurol Neurosurg. 2005 Jun;107(4):306-9</RefSource>
<PMID Version="1">15885389</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2005 Oct;252(10):1201-5</RefSource>
<PMID Version="1">16151602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2006;44(2):275-88</RefSource>
<PMID Version="1">15964035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2006;44(3):339-49</RefSource>
<PMID Version="1">16061263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2006;138(3):1015-20</RefSource>
<PMID Version="1">16310318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2006 May 15;59(10):966-74</RefSource>
<PMID Version="1">16616726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Synapse. 2006 Oct;60(5):354-61</RefSource>
<PMID Version="1">16838362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 2006 Nov;147(11):5303-13</RefSource>
<PMID Version="1">16916950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2007 Mar 27;68(13):1062-8</RefSource>
<PMID Version="1">17389313</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Steroids. 2007 May;72(5):381-405</RefSource>
<PMID Version="1">17379265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Neurol. 2007 Jun;14(6):632-7</RefSource>
<PMID Version="1">17539940</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Pharmacol Physiol. 2007 Jul;34(7):555-65</RefSource>
<PMID Version="1">17581209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gend Med. 2007 Mar;4(1):8-18</RefSource>
<PMID Version="1">17584622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):819-24</RefSource>
<PMID Version="1">17098842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Jun 15;22(8):1150-6</RefSource>
<PMID Version="1">17469208</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2008;14(2):93-101</RefSource>
<PMID Version="1">17707678</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2008 Feb;255(2):255-64</RefSource>
<PMID Version="1">18204803</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Front Neuroendocrinol. 2008 May;29(2):313-39</RefSource>
<PMID Version="1">18374402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2008 Apr 15;70(16 Pt 2):1390-6</RefSource>
<PMID Version="1">18413566</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2008 May;131(Pt 5):1294-302</RefSource>
<PMID Version="1">18362097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2008;46(9):2300-9</RefSource>
<PMID Version="1">18485422</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2008 Jul 15;163(2):171-82</RefSource>
<PMID Version="1">18504119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):789-95</RefSource>
<PMID Version="1">17965146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2008 Aug;131(Pt 8):2094-105</RefSource>
<PMID Version="1">18577547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2008 Nov;131(Pt 11):2882-93</RefSource>
<PMID Version="1">18957454</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Neurosci. 2009 Feb;123(1):125-36</RefSource>
<PMID Version="1">19170437</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Neurol. 2009;61(3):164-70</RefSource>
<PMID Version="1">19129703</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychol Aging. 2009 Sep;24(3):542-9</RefSource>
<PMID Version="1">19739910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Int Neuropsychol Soc. 2010 Jan;16(1):49-57</RefSource>
<PMID Version="1">19758475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Maturitas. 2010 Apr;65(4):352-8</RefSource>
<PMID Version="1">20117891</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2010 Jun;62(2):155-98</RefSource>
<PMID Version="1">20392807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2010 Jun;48(7):1901-13</RefSource>
<PMID Version="1">20230847</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2000 Jul;102(1):37-43</RefSource>
<PMID Version="1">10893061</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003071">Cognition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004967">Estrogens</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D012727">Sex Characteristics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS222472</OtherID>
<OtherID Source="NLM">PMC3003756</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.23388</ArticleId>
<ArticleId IdType="pubmed">20925068</ArticleId>
<ArticleId IdType="pmc">PMC3003756</ArticleId>
<ArticleId IdType="mid">NIHMS222472</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
</list>
<tree><noCountry><name sortKey="Cronin Golomb, Alice" sort="Cronin Golomb, Alice" uniqKey="Cronin Golomb A" first="Alice" last="Cronin-Golomb">Alice Cronin-Golomb</name>
</noCountry>
<country name="États-Unis"><region name="Massachusetts"><name sortKey="Miller, Ivy N" sort="Miller, Ivy N" uniqKey="Miller I" first="Ivy N" last="Miller">Ivy N. Miller</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001865 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001865 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:20925068
   |texte=   Gender differences in Parkinson's disease: clinical characteristics and cognition.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:20925068" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Gender differences in Parkinson's disease: clinical characteristics and cognition.

Gender differences in Parkinson's disease: clinical characteristics and cognition.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki